Category: microRNA

Role of Nampt overexpression in a rat model of Hashimoto's thyroiditis and its mechanism of action.
Trichuris muris infection drives cell-intrinsic IL4R alpha independent colonic RELMα+ macrophages
Chimeric Antigen Receptor-T Cells: A Pharmaceutical Scope
Immune inactivation of anti-simian immunodeficiency virus chimeric antigen receptor T cells in rhesus macaques
Identification of Cross-Reactive CD8 + T Cell Receptors with High Functional Avidity to a SARS-CoV-2 Immunodominant Epitope and Its Natural Mutant Variants

Identification of Cross-Reactive CD8 + T Cell Receptors with High Functional Avidity to a SARS-CoV-2 Immunodominant Epitope and Its Natural Mutant VariantsIdentification of Cross-Reactive CD8 + T Cell Receptors with High Functional Avidity to a SARS-CoV-2 Immunodominant Epitope and Its Natural Mutant Variants

| HunterHunter | 0 Comment

Regardless of the rising data of T cell responses in COVID-19 sufferers, there’s a lack of detailed characterizations for T cell-antigen interactions and T cell features. Right here, with a

READ MOREREAD MORE
Rapid statistical discrimination of fluorescence images of T cell receptors on immobilizing surfaces with different coating conditions

Rapid statistical discrimination of fluorescence images of T cell receptors on immobilizing surfaces with different coating conditionsRapid statistical discrimination of fluorescence images of T cell receptors on immobilizing surfaces with different coating conditions

| HunterHunter | 0 Comment

The spatial group of T cell receptors (TCRs) correlates with membrane-associated sign amplification, dispersion, and regulation throughout T cell activation. Regardless of its potential medical significance, quantitative evaluation of the

READ MOREREAD MORE
Successful Chimeric Antigen Receptor (CAR) T-Cell Treatment in Aggressive Lymphoma Despite Coronavirus Disease 2019 (CoVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication - Case Report

Successful Chimeric Antigen Receptor (CAR) T-Cell Treatment in Aggressive Lymphoma Despite Coronavirus Disease 2019 (CoVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication – Case ReportSuccessful Chimeric Antigen Receptor (CAR) T-Cell Treatment in Aggressive Lymphoma Despite Coronavirus Disease 2019 (CoVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication – Case Report

| HunterHunter | 0 Comment

In sufferers with compromised immune operate, extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2) an infection and coronavirus illness 2019 (CoVID-19) impose specific challenges. Particularly in hematological malignancies, together with lymphoma,

READ MOREREAD MORE
Chimeric non-antigen receptors in T cell-based cancer therapy
Can Glycosylation Mask the Detection of MHC Expressing p53 Peptides by T Cell Receptors?
Increasing LFA-1 Expression Enhances Immune Synapse Architecture and T Cell Receptor Signaling in Jurkat E6.1 Cells